Making a
difference.
It's in our DNA.

Jack Harkema, DVM PhD DACVP ATSF

University Distinguished Professor
Pathobiology & Diagnostic Investigation, Pharmacology & Toxicology
(517) 353-8627
212 Food Safety and Toxicology Building

Bio

I am a board-certified veterinary pathologist with extensive experience in pulmonary pathology of laboratory animals. I have been an academic biomedical researcher and mentor of graduate/medical/veterinary students, pathology residents, and postdoctoral fellows for over 30 years in the areas of respiratory toxicology and pathology. My personal research focuses on the elucidation of biological mechanisms underlying airway epithelial cell injury, repair, and disrepair to xenobiotics (e.g., air pollutants, allergens, viruses, microbial toxins). Much of my recent research has focused on developing animal models of human respiratory, cardiovascular, metabolic, and autoimmune diseases (e.g., asthma, metabolic syndrome, systemic lupus erythematosus) used to investigate how pre-existing disease may affect an individual’s susceptibility to air pollutants (e.g., particulate matter, ozone). My career has been fostered by a network of extensive and highly productive collaborations reflected in over 290 publications with coauthors from 20+ units at Michigan State University (MSU) and more than 100 national and international laboratories. More recent collaborative activities with others at MSU and elsewhere are based on my experience with animal studies designed to better understand the pathogenesis of pulmonary diseases caused by inhaled toxic agents, e.g., air pollutants, as well as interventions to prevent/treat environmental triggers of chronic human diseases, such as diabetes, lupus, and asthma.

Associations

  • Director, Laboratory for Environmental and Toxicologic Pathology

Education

  • Ph.D., Pathology (School of Veterinary Medicine), University of California, Davis ()
  • Postdoctoral Fellow, Inhalation Toxicology, Lovelace Respiratory Research Institute ()
  • D.V.M., Veterinary Medicine, Michigan State University ()
  • M.S., Physiology, Michigan State University ()
  • B.S., Biology, Calvin University ()

Funding

  • Genetic Analysis of COVID-19 Susceptibility and Resistance Determinants in the Collaborative Cross, National Institute of Allergy and Infectious Diseases (2022—2023)
  • Dietary Lipids and Silica-Triggered Autoimmunity, National Institute of Environmental Health Sciences (2017—2023)
  • Role of alveolar macrophage in omega-3 fatty acid amelioration of silica-triggered autoimmunity, National Institute of Environmental Health Sciences (2023—2027)
  • Toxic lipid intermediate accumulation and cobalamin depletion promote AHR-mediated hepatotoxicity and the progression of non-alcoholic fatty liver disease (NAFLD)-like pathologies, National Institute of Environmental Health Sciences (2022—2027)
  • Gene-Environment Interactions with Ozone and Non-atopic Asthma, National Institute of Environmental Health Sciences (2021—2023)
  • Impact of Particle and Ozone Inhalation Co-Exposure on Alveolar Epithelial Regeneration, National Institute of Environmental Health Sciences ()
  • Computational Modeling of Aerosol Dosimetry in the Ferret Respiratory Tract, Cystic Fibrosis Foundation (2021—2024)

Works

Employment

  • University Distinguished Professor, Michigan State University (2019-05-01)
  • University Distinguished Professor, Michigan State University (1994-08-01)
  • Senior Staff Scientist/Pathologist, Lovelace Respiratory Research Institute (1985-11-01—1995-07-15)